SeaStar Medical Holding (ICU) Operating Expenses (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Operating Expenses came in at $4.1 million in Q1 2026, down 1.53% YoY from $4.1 million in Q1 2025, and up 18.34% on a QoQ basis from $3.4 million in Q4 2025.
SeaStar Medical Holding (ICU) Operating Expenses (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of Operating Expenses data on file, last reported at $4.1 million in Q1 2026.
- Quarterly Operating Expenses fell 1.53% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (down 26.74% YoY) and the FY2025 annual result came in at $13.4 million, down 25.71% from the prior year.
- Operating Expenses improved to $4.1 million in Q1 2026, from $3.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $7.7 million in Q4 2022 to a low of $812000.0 in Q1 2022.
- A 5-year average of $3.6 million and a median of $3.8 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 724.42% — and 2023, when it tumbled 61.94%.
- Tracing ICU's Operating Expenses over 5 years: stood at $7.7 million in 2022, then slumped by 61.94% to $2.9 million in 2023, then jumped by 64.59% to $4.8 million in 2024, then retreated by 29.17% to $3.4 million in 2025, then climbed by 18.34% to $4.1 million in 2026.
- The last three Operating Expenses figures came in at $4.1 million (Q1 2026), $3.4 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 541.02 Mn |
| 10 | SeaStar Medical Holding | 13.89 Mn | 6.89 Mn | 561,000.00 | 4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.35 Mn |
| Mar 31, 2026 | 4.05 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Sep 30, 2024 | 4.52 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Mar 31, 2024 | 3.95 Mn |
| Dec 31, 2023 | 2.94 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 3.75 Mn |
| Mar 31, 2023 | 4.58 Mn |
| Dec 31, 2022 | 7.72 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 812,000.00 |
| Dec 31, 2021 | 935,927.00 |
| Sep 30, 2021 | 411,398.00 |